Glass House Brands (GLAS) Capital Expenditures (2020 - 2026)

Glass House Brands' (GLAS) quarterly Capital Expenditures came in at -$3.5 million in Q1 2026, up 47.04% year-on-year from -$2.4 million in Q1 2025, and down 116.62% on a QoQ basis from $21.3 million in Q4 2025.

Glass House Brands (GLAS) Capital Expenditures (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Capital Expenditures data on file, last reported at -$3.5 million in Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 47.04% year-over-year to -$3.5 million in Q1 2026; TTM through Mar 2026 was -$293000.0, a 104.88% decrease from a year earlier, with the FY2025 full-year figure at -$3.4 million, down 133.44% from the prior year.
  • Capital Expenditures for Q1 2026 stood at -$3.5 million, down from $21.3 million in the prior quarter.
  • Over the last five years, Capital Expenditures for GLAS reached as high as $21.3 million in Q4 2025 and fell as low as -$9.5 million in Q2 2025.
  • Historically, Capital Expenditures has averaged $1.5 million across 5 years, with a median of -$1.4 million in 2024.
  • Across the five-year window, Capital Expenditures soared 1404.77% in 2022 and slumped 1999.03% in 2024, its largest moves.
  • Year by year, Capital Expenditures stood at $4.1 million in 2022, then soared by 47.85% to $6.0 million in 2023, then soared by 198.35% to $18.0 million in 2024, then gained by 18.35% to $21.3 million in 2025, then sank by 116.62% to -$3.5 million in 2026.
  • Per Business Quant data, the three most recent Capital Expenditures figures were -$3.5 million in Q1 2026, $21.3 million in Q4 2025, and -$8.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 168.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 99.60 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 51.00 Mn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn -3.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.55 Mn
Mar 31, 2026 -3.55 Mn
Dec 31, 2025 21.34 Mn
Dec 31, 2025 21.34 Mn
Sep 30, 2025 -8.63 Mn
Sep 30, 2025 -8.63 Mn
Jun 30, 2025 -9.46 Mn
Jun 30, 2025 -9.46 Mn
Mar 31, 2025 -6.70 Mn
Mar 31, 2025 -6.70 Mn
Dec 31, 2024 18.03 Mn
Dec 31, 2024 18.03 Mn
Sep 30, 2024 -1.42 Mn
Sep 30, 2024 -1.42 Mn
Jun 30, 2024 -3.91 Mn
Jun 30, 2024 -3.91 Mn
Mar 31, 2024 -2.41 Mn
Mar 31, 2024 -2.41 Mn
Dec 31, 2023 6.04 Mn
Dec 31, 2023 6.04 Mn